Crystal Cazier serves as an Associate at the George W. Bush Institute. In this role, she helps coordinate the Bush Institute’s involvement in The Partnership to End AIDS and Cervical Cancer, a collaboration of the Bush Institute, PEPFAR, and UNAIDS that works with eight countries in sub-Saharan Africa to prioritize HIV-positive women in national cervical cancer prevention and control programs. She also serves on the research and evaluation team which supports programming across the Bush Institute.
Before joining the Bush Institute, Crystal worked as a Clinical Research Associate at Carle Cancer Center in Urbana, Illinois where she managed budgetary and contractual negotiations for both pharmaceutical and government-sponsored clinical trials.
Crystal received her undergraduate degree from the University of Illinois in Urbana-Champaign and is currently pursuing a Master of Public Health at the University of Texas Health Science Center.
Related Articles and Resources
PEPFAR Changes the Equation
PEPFAR: a look in the rearview mirror and the road that lies ahead
Cervical Cancer Awareness Month: 4 Things to Know
Cervical cancer is the fourth most common cancer in women worldwide. Data from 2012 indicates there are approximately 528,000 new cases of cervical cancer every year, and for every two new cases of cervical cancer, at least one woman succumbs to the disease – an estimated 266,000 women die of cervical cancer annually. During Cervical Cancer Awareness month, here are some important things to know about cervical cancer and how the world is responding. Low and Middle Income Countries Bear the Burden of Cervical Cancer Cervical cancer disproportionately affects women in low and middle income countries (LMICs). More than 80 percent of cervical cancer cases occur in low-resource settings. The burden is particularly stark in LMICs where cervical cancer affects women during the prime of their lives. Women are at the center of society as primary caregivers for children, engaged community leaders, and contributors to economic growth and prosperity. Whe
14 Things to Know About the Life-Saving Work of PEPFAR on its 14th Anniversary
This weekend marks the 14th anniversary of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief, which President George W. Bush signed into law on May 27, 2003 as part of the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003. Since then PEPFAR has saved nearly 12 million lives. Here’s a look at 14 interesting facts about PEPFAR, which has lead the progress in the global campaign to end AIDS. In 2003, at the signing of the PEPFAR legislation, less than 50,000 people in sub-Saharan Africa were on antiretroviral treatment (ART) for HIV/AIDS, now 11.5 million individuals are on ART due to PEPFAR. 99.5 percent of HIV-positive pregnant women are receiving ART, a more than 40 percent increase since the beginning of 2014. This has led to nearly 2 million babies being born HIV-free to infected mothers. Since the start of PEPFAR, new HIV Infections have declined 51 to 76 percent. Voluntary medical male circumcision (VMMC) can reduce men&rs
Beyond Lives Saved
PEPFAR lifts up societies and increases opportunities for growth, stability and prosperity.
A Tale of Two Realities
While the Olympics attempts to elevate countries to the same playing field, there are usually clear winners and losers. Global cervical cancer statistics reveal a similar story.
Thembi’s Plea: How a Vaccine Helps Ensure African Girls Have an Opportunity to Succeed
We join Thembi, a bold ten-year-old school girl in Botswana, in reaffirming the importance of the HPV vaccine to protect girls from cervical cancer while they are still young.
Reflections on Mother’s Day : The Generational Impact of PEPFAR
This year, we are celebrating progress due in large part to PEPFAR, and also the commitment of the international community, and the leadership of National Governments to work toward an AIDS-free generation. Because of PEPFAR -- nearly two million babies have been born HIV-free to mothers who live with HIV/AIDS.
A Look Back at Pink Ribbon Red Ribbon in 2016
Pink Ribbon Red Ribbon is closing a momentous year of transition and growth. The partnership marked its fifth anniversary, began operating as an independent non-profit organization affiliated with the George W. Bush Institute, welcomed new leadership, established an office in Washington, D.C., and expanded its team of talented staff to advance Pink Ribbon Red Ribbon’s mission of fighting women’s cancer in sub-Saharan Africa and Latin America. In 2016, much was accomplished to save the lives of women and girls from breast and cervical cancer in countries where there is a particularly high burden of disease. With Pink Ribbon Red Ribbon’s partners and supporters, we celebrate: Finalizing plans for an investment of $3.5 million in financing from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to support the transition of the Zambian cervical cancer program to the Ministry of Health by 2019; Opening 12 new sites to screen for an
7 Things to Know about PEPFAR on World AIDS Day
Today marks World AIDS Day: a day to honor those lost, celebrate the global progress made in the fight against AIDS, and commit to put an end to the disease. In 2003, at the signing ceremony for the legislation that enacted the President’s Emergency Plan for AIDS Relief (PEPFAR), President George W. Bush said, “We believe in the value and dignity of every human life. In the face of preventable death and suffering, we have a moral duty to act, and we are acting.” Since then, PEPFAR has delivered life-saving antiretroviral treatment (ART) to 11.5 million people, and nearly 2 million babies have been born HIV-free with PEPFAR support. PEPFAR’s success contributes to a coordinated global effort to end AIDS. UNAIDS reports that since 2000, 18.2 million people have access to treatment for HIV, new infections of HIV have decreased by over 1 million infections, and AIDS-related deaths have decreased by 1.4 million. There is real hope for endin
Series on Health, Equity, and Women’s Cancers Published in The Lancet Draws Global Attention to Cervical and Breast Cancer
Cervical and breast cancers are the common-most cancers among women living in low-income and middle-income countries (LMICs) but remain severely under-resourced, under-researched and their effects under-publicized. A series of papers published this week in The Lancet, and released at the UICC World Cancer Congress in Paris, France, draws attention to the global burden of breast and cervical cancer, giving stark focus to the burden of these diseases in LMICs. The authors estimate that if efforts are not amplified, the number of women diagnosed with breast cancer worldwide could nearly double per year to 3.2 million new cases per year in 2030. That’s compared with 1.7 million new cases in 2012, and the number of women diagnosed with cervical cancer per year could increase by 32 percent, from 530,000 new cases per year in 2012, to 700,000 per year in 2030 if incidence rates do not change. While evidence shows that prevention, screening and treatment services, coupled w
On the 5th Anniversary of Pink Ribbon Red Ribbon, A Look Back at How it All Began
This fall marks the 5th anniversary of Pink Ribbon Red Ribbon, a partnership that leads coordinated action to save women’s lives from cancer. The organization has made great strides in fighting women’s cancers, working to provide prevention, screening and treatment services to women in Botswana, Tanzania, Zambia, Ethiopia, and Namibia. But what is now a global partnership was once just a simple idea. While traveling in Tanzania with President Bush in 2008, founder of Susan G. Komen® Ambassador Nancy Brinker wondered aloud if there could be an initiative similar to the President’s Emergency Plan for AIDS Relief (PEPFAR) to provide a response to breast cancer. After their time in the White House, President and Mrs. Bush explored possible global health efforts that would appropriately leverage the impact of PEPFAR. PEPFAR was effectively addressing the HIV/AIDS epidemic, but women were surviving HIV only to die of cervical cancer. To intervene and